Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a […]
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a […]
